← 홈

ADC

1,068개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-12 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,068개
ADCBiologicstaleShanghai Fudan-Zhangjiang Bio-P…Phase 1

FDA018-ADC (FDA018-ADC)

Advanced/ Metastatic Solid Tumors · Triple Negative Breast Cancer

#TripleNegativeBreastCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING
ADCBiologicstaleShanghai Fudan-Zhangjiang Bio-P…Phase 2

FDA022-BB05 (FDA022-BB05)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 ACTIVE
ADCBiologicstaleAstraZenecaPhase 1

FPI-2053 (FPI-2053)

Advanced Solid Tumor; Metastatic Colorectal Carcinoma · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleShanghai Fudan-Zhangjiang Bio-P…Phase 1

FZ-AD005 (FZ-AD005)

High Grade Glioma (III or IV); Diffuse Midline Glioma (DMG) · High Grade Glioma (III or IV)

#HighGradeGliomaIIIorIV#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleGeneQuantum Healthcare (Suzhou)…Phase 1

GQ1001 (GQ1001)

HER2-positive Breast Cancer; HER2-positive Biliary Tract Cancer · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 ACTIVE
ADCBiologicGeneQuantum Healthcare (Suzhou)…-mediatedPhase 3

GQ1005 (GQ1005)

HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+4
임상시험 2상태 RECRUITING
ADCBiologicstaleGlaxoSmithKlinePhase 3

GSK5733584 (GSK5733584)

Neoplasms, Endometrial · Neoplasms, Endometrial

#NeoplasmsEndometrial#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING
ADCBiologicstaleShanghai Henlius BiotechPhase 3

HLX87 + HLX22 (HLX87 + HLX22)

HER2 + Breast Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleAbbViePhase 1

IMGN151 (IMGN151)

Endometrial Cancer; High Grade Serous Adenocarcinoma of Ovary · Endometrial Cancer

#EndometrialCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleSeagenPhase 2

brentuximab vedotin (Adcetris, Induction without Brentuximab Vedotin)

Hodgkin Lymphoma, Adult · Hodgkin Lymphoma, Adult

#HodgkinLymphomaAdult#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING
ADCBiologicstaleJanssen Research & Development,…Phase 1

JNJ-95298177 (JNJ-95298177)

Prostatic Neoplasms · Prostatic Neoplasms

#ProstaticNeoplasms#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 RECRUITING
ADCBiologicstaleEli Lilly and CompanyPhase 1

LY4170156 (LY4170156)

Ovarian Neoplasms; Endometrial Neoplasms · Ovarian Neoplasms

#OvarianNeoplasms#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleEMD Serono Research & Developme…Phase 2

M6223 (M6223)

Metastatic Solid Tumors · Locally Advanced or Metastatic Urothelia

#LocallyAdvancedorMetastaticUroth#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleMenarini GroupPhase 1

MEN1309 (MEN1309)

Metastatic Solid Tumors; Relapsed/Refractory Non-Hodgkin Lymphoma · FRα

#FR#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+4
임상시험 2상태 DISCONTINUED
ADCBiologicLepu Biopharma Co., Ltd.Phase 2

MRG006A (MRG006A)

Hepatocellular Carcinoma · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicstaleOncomatryx Biopharma S.L.Phase 1

OMTX705 (OMTX705)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 2상태 RECRUITING
ADCBiologicstalePfizerPhase 3

PF-08046054 (PF-08046054)

Non-small Cell Carcinoma; Non-Small Cell Lung Cancer Metastatic · Non-small Cell Carcinoma

#Non-smallCellCarcinoma#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING
ADCBiologicPyxis Oncology, IncthroughPhase 2

PYX-201 (PYX-201)

Advanced Solid Tumors · Solid Tumor

#SolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
임상시험 2상태 RECRUITING
ADCBiologicstaleGenentech, Inc.Phase 2

Pinatuzumab Vedotin (Pinatuzumab Vedotin)

Follicular Lymphoma; Diffuse Large B-Cell Lymphoma · Follicular Lymphoma

#FollicularLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 6.24%임상시험 2상태 ACTIVE
ADCBiologicstaleAstraZenecaPhase 3

Puxitatug Samrotecan (Puxitatug Samrotecan)

Endometrial Cancer; Malignant Solid Tumour · Endometrial Cancer

#EndometrialCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 2상태 RECRUITING

33 / 54 페이지

← 이전다음 →